Repligen Gross Profit 2006-2019 | RGEN

Repligen annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Repligen gross profit for the quarter ending September 30, 2019 was $0.038B, a 39.03% increase year-over-year.
  • Repligen gross profit for the twelve months ending September 30, 2019 was $0.140B, a 37.9% increase year-over-year.
  • Repligen annual gross profit for 2018 was $0.108B, a 44.91% increase from 2017.
  • Repligen annual gross profit for 2017 was $0.074B, a 29.19% increase from 2016.
  • Repligen annual gross profit for 2016 was $0.057B, a 18.92% increase from 2015.
Repligen Annual Gross Profit
(Millions of US $)
2018 $108
2017 $74
2016 $57
2015 $48
2014 $36
2013 $43
2012 $35
2011 $
2011 $20
2010 $15
2009 $23
2008 $13
2007 $10
2006 $9
2005 $5
Repligen Quarterly Gross Profit
(Millions of US $)
Q3 2019 $38
Q2 2019 $40
Q1 2019 $34
Q4 2018 $28
Q3 2018 $27
Q2 2018 $27
Q1 2018 $25
Q4 2017 $22
Q3 2017 $17
Q2 2017 $19
Q1 2017 $17
Q4 2016 $13
Q3 2016 $13
Q2 2016 $17
Q1 2016 $14
Q4 2015 $11
Q3 2015 $11
Q2 2015 $13
Q1 2015 $13
Q4 2014 $8
Q3 2014 $8
Q2 2014 $9
Q1 2014 $10
Q4 2013 $10
Q3 2013 $12
Q2 2013 $12
Q1 2013 $9
Q4 2012 $12
Q3 2012 $8
Q2 2012 $8
Q1 2012 $7
Q4 2011
Q3 2011 $6
Q2 2011 $6
Q1 2011 $4
Q4 2010 $5
Q3 2010 $5
Q2 2010 $5
Q1 2010
Q4 2009 $4
Q3 2009 $4
Q2 2009 $3
Q1 2009
Q4 2008 $4
Q3 2008 $4
Q2 2008 $11
Q1 2008
Q4 2007 $3
Q3 2007 $4
Q2 2007 $4
Q1 2007
Q4 2006 $3
Q3 2006 $2
Q2 2006 $3
Q1 2006
Q4 2005 $2
Q3 2005 $2
Q2 2005 $3
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.518B $0.194B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.754B 14.95
CSL (CSLLY) Australia $100.067B 0.00
Gilead Sciences (GILD) United States $84.777B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.762B 57.87
Biogen (BIIB) United States $58.677B 10.02
Illumina (ILMN) United States $44.088B 45.58
Regeneron Pharmaceuticals (REGN) United States $43.749B 18.53
Alexion Pharmaceuticals (ALXN) United States $22.618B 10.52
Seattle Genetics (SGEN) United States $20.666B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.190B 36.88
BioMarin Pharmaceutical (BMRN) United States $15.976B 0.00
Genmab (GNMSF) Denmark $14.806B 65.39
Alnylam Pharmaceuticals (ALNY) United States $14.487B 0.00
Galapagos (GLPG) Belgium $14.474B 37.29
Exact Sciences (EXAS) United States $12.931B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.431B 0.00
Sarepta Therapeutics (SRPT) United States $9.152B 0.00
QIAGEN (QGEN) Netherlands $8.272B 25.47
Guardant Health (GH) United States $7.994B 0.00
Bio-Techne Corp (TECH) United States $7.914B 54.16
BioNTech SE (BNTX) Germany $7.136B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.999B 0.00
Reata Pharmaceuticals (RETA) United States $6.906B 0.00
Ascendis Pharma (ASND) Denmark $6.762B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.685B 17.00
Amarin (AMRN) Ireland $6.498B 0.00
Exelixis (EXEL) United States $6.451B 18.15
Moderna (MRNA) United States $6.364B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.102B 0.00
Acceleron Pharma (XLRN) United States $5.006B 0.00
Bluebird Bio (BLUE) United States $4.881B 0.00
China Biologic Products (CBPO) China $4.581B 25.81
Adaptive Biotechnologies (ADPT) United States $3.948B 0.00
MorphoSys AG (MOR) Germany $3.881B 0.00
Mirati Therapeutics (MRTX) United States $3.814B 0.00
Blueprint Medicines (BPMC) United States $3.572B 0.00
Immunomedics (IMMU) United States $3.560B 0.00
NeoGenomics (NEO) United States $3.559B 189.36
Zai Lab (ZLAB) China $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.537B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.389B 57.41
Emergent Biosolutions (EBS) United States $3.293B 32.71
MyoKardia (MYOK) United States $3.269B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.251B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.171B 0.00
Genmab (GMAB) Denmark $3.099B 6.38
Halozyme Therapeutics (HALO) United States $3.095B 0.00
Alkermes (ALKS) Ireland $2.779B 220.13
Amicus Therapeutics (FOLD) United States $2.755B 0.00
UniQure (QURE) Netherlands $2.735B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.713B 6.31
Denali Therapeutics (DNLI) United States $2.517B 0.00
Epizyme (EPZM) United States $2.300B 0.00
Principia Biopharma (PRNB) United States $2.279B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Fate Therapeutics (FATE) United States $2.187B 0.00
Alector (ALEC) United States $1.998B 0.00
REGENXBIO (RGNX) United States $1.966B 0.00
Zymeworks (ZYME) Canada $1.900B 0.00
Ligand Pharmaceuticals (LGND) United States $1.722B 50.28
Arvinas (ARVN) United States $1.685B 0.00
Akcea Therapeutics (AKCA) United States $1.640B 0.00
Coherus BioSciences (CHRS) United States $1.554B 0.00
Zealand Pharma (ZEAL) Denmark $1.513B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Myriad Genetics (MYGN) United States $1.465B 25.85
Dicerna Pharmaceuticals (DRNA) United States $1.393B 0.00
Editas Medicine (EDIT) United States $1.381B 0.00
Intra-Cellular Therapies (ITCI) United States $1.327B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.225B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.216B 0.00
Revance Therapeutics (RVNC) United States $1.170B 0.00
PHARMA MAR SA (PHMMF) Spain $1.157B 0.00
Twist Bioscience (TWST) United States $1.083B 0.00
Adverum Biotechnologies (ADVM) United States $1.054B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Cytokineticsorporated (CYTK) United States $0.963B 0.00
Mesoblast (MESO) Australia $0.920B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
DBV Technologies S.A (DBVT) France $0.884B 0.00
Sangamo Therapeutics (SGMO) United States $0.867B 0.00
Vericel (VCEL) United States $0.848B 316.33
Codexis (CDXS) United States $0.827B 0.00
Heska (HSKA) United States $0.806B 205.94
ANI Pharmaceuticals (ANIP) United States $0.783B 13.36
Cellectis S.A (CLLS) France $0.723B 0.00
Intrexon (PGEN) United States $0.719B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.713B 6.00
Retrophin (RTRX) United States $0.710B 0.00
Cara Therapeutics (CARA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.665B 0.00
Intellia Therapeutics (NTLA) United States $0.657B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Kadmon Holdings (KDMN) United States $0.629B 0.00
UROGEN PHARMA (URGN) United States $0.625B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.608B 0.00
Anika Therapeutics (ANIK) United States $0.605B 19.63
NantKwest (NK) United States $0.584B 0.00
Arcus Biosciences (RCUS) United States $0.570B 0.00
AC Immune SA (ACIU) Switzerland $0.563B 13.03
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.540B 0.00
Agenus (AGEN) United States $0.536B 0.00
Cel-Sci (CVM) United States $0.533B 0.00
Puma Biotechnology (PBYI) United States $0.518B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
Bellus Health (BLU) Canada $0.507B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
BioDelivery Sciences (BDSI) United States $0.476B 0.00
Compugen (CGEN) Israel $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Sorrento Therapeutics (SRNE) United States $0.443B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.438B 0.00
Dynavax Technologies (DVAX) United States $0.429B 0.00
AnaptysBio (ANAB) United States $0.428B 0.00
Inovio Pharmaceuticals (INO) United States $0.428B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Precision BioSciences (DTIL) United States $0.415B 0.00
PDL BioPharma (PDLI) United States $0.414B 10.37
Cue Biopharma (CUE) United States $0.414B 0.00
Pfenex (PFNX) United States $0.411B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.410B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Mersana Therapeutics (MRSN) United States $0.407B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Gritstone Oncology (GRTS) United States $0.361B 0.00
Stemline Therapeutics (STML) United States $0.353B 0.00
CytomX Therapeutics (CTMX) United States $0.346B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Syros Pharmaceuticals (SYRS) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.306B 2.12
MannKind (MNKD) United States $0.303B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.301B 0.00
Aduro Biotech (ADRO) United States $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.294B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
WAVE Life Sciences (WVE) Singapore $0.287B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
IVERIC Bio (ISEE) United States $0.269B 0.00
Kamada (KMDA) Israel $0.268B 11.17
Geron (GERN) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Novavax (NVAX) United States $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.246B 0.00
Kala Pharmaceuticals (KALA) United States $0.241B 0.00
ChromaDex (CDXC) United States $0.239B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.237B 0.00
Protagonist Therapeutics (PTGX) United States $0.234B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.228B 11.69
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.218B 0.00
Alcobra (ARCT) United States $0.214B 0.00
Prometic Life Sciences (LMNL) Canada $0.214B 0.00
Arbutus Biopharma (ABUS) Canada $0.211B 0.00
Theratechnologies (THTX) Canada $0.211B 0.00
Cerecor (CERC) United States $0.210B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.207B 0.00
Affimed (AFMD) Germany $0.207B 0.00
TELA Bio (TELA) United States $0.205B 0.00
Fortress Biotech (FBIO) United States $0.204B 0.00
Exicure (XCUR) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.198B 0.00
Athersys (ATHX) United States $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 4.91
Abeona Therapeutics (ABEO) United States $0.179B 0.00
Spero Therapeutics (SPRO) United States $0.174B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Selecta Biosciences (SELB) United States $0.163B 0.00
Five Prime Therapeutics (FPRX) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Aptinyx (APTX) United States $0.156B 0.00
Verastem (VSTM) United States $0.153B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Celyad SA (CYAD) Belgium $0.151B 0.00
Liquidia Technologies (LQDA) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
ARAVIVE, INC (ARAV) United States $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.138B 0.00
Palatin Technologies (PTN) United States $0.137B 3.73
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.130B 0.00
Arsanis (XFOR) United States $0.127B 0.00
OvaScience (MLND) United States $0.125B 0.00
Prima BioMed (IMMP) Australia $0.118B 0.00
Clearside Biomedical (CLSD) United States $0.117B 0.00
Happiness Biotech Group (HAPP) China $0.117B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Applied Genetic Technologies (AGTC) United States $0.098B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Checkpoint Therapeutics (CKPT) United States $0.085B 0.00
AIT Therapeutics (XAIR) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.081B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Acorda Therapeutics (ACOR) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.077B 4.97
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Bioxytran (BIXT) United States $0.065B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Advaxis (ADXS) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
Soligenix (SNGX) United States $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.053B 0.00
Idera Pharmaceuticals (IDRA) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Celsion (CLSN) United States $0.030B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
IBio (IBIO) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00